Back to discover
Drug

Methadone

Approved · FDA
Emerging researchLate-stage developmentRising momentum
Also known as Diskets, Dolophine, dl-Methadone, (+-)-Methadone+7 more

Diskets, Dolophine, dl-Methadone, (+-)-Methadone, (±)-methadone, Metadona, Methadose, (+/-)-Methadone, 6-Dimethylamino-4,4-diphenyl-3-heptanone, Methadone Hydrochloride, Methadonum.

3
Research papers
31
Active clinical trials
8
Regulatory events
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Oral Methadone In Cardiac Surgery

Clinical trial2026-06-30Primary completion · ClinicalTrials.gov

A Clinical Trial to Study the Effect of a Single Dose of Ulonivirine on the Pharmacokinetics of Methadone

Clinical trial2026-06-23Results expected Q1 2027 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Methadone
Aliases & brands
DisketsDolophinedl-Methadone(+-)-Methadone(±)-methadoneMetadonaMethadose(+/-)-Methadone6-Dimethylamino-4,4-diphenyl-3-heptanoneMethadone HydrochlorideMethadonum
RxNorm CUI
6813
ChEMBL ID
CHEMBL651
UNII
UC6VBE7V1Z
Regulatory jurisdictions
fda

Regulatory timeline

8 events

The complete regulatory record, grouped by authority — approvals, safety advisories and label changes. Each authority shows its most recent events; expand one to read its full history.

Earliest approval
2020-03-16
Latest approval
2026-06-18
Authorities
FDA
Total events
8
fdaU.S. Food and Drug Administration· 8 events
2026-06-18Supplemental approval
Supplemental approval: METHADONE (ANDA204166)
Evidence ↗
2025-12-23Label change
Label change: METHADONE (ANDA204166)
Evidence ↗
2025-03-27Label change
Label change: METHADONE (ANDA204166)
Evidence ↗

Data from the U.S. Food and Drug Administration (U.S. Food and Drug Administration), public domain (CC0).

Clinical trials

163 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
163
registered trials across all phases
LATEST COMPLETION 2025
31
Active studies
27
Recruiting
108
Late-stage (III+)
92
Completed
40
Discontinued
PHASE DISTRIBUTIONn = 163
Early Phase 14Phase 129Phase 1 / 25Phase 217Phase 2 / 33Phase 336Phase 452Phase N / A17

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

3 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
20132024
Major research themes8
Analgesics, Opioid1Intraoperative Care1Maintenance Chemotherapy1Methadone1Opiate Substitution Treatment1Pain Management1Postoperative Pain1Tonsillectomy1
Journals, researchers & institutions
Top journals
  • Anesthesiology1
  • Drug and alcohol dependence1
  • European journal of clinical pharmacology1
Leading researchers
  • Bruce RD2
  • Ang A1
  • Bilangi R1
  • Butterton JR1
  • Cohen A1
  • Doraimani G1
  • Einhorn LM1
  • Feng HP1
Leading institutions
free-text, unnormalised
  • Department of Clinical Pharmacology1
  • Duke Molecular Physiology Institute1
  • Duke University School of Medicine1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials
  • Regulatory event sources are credited in the Regulatory Timeline above.